News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
136 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27452)
Month
January (3339)
February (3294)
March (4068)
April (3456)
May (4782)
June (3455)
July (2689)
August (3589)
September (3334)
October (3976)
November (4082)
December (2500)
Day
1 (2)
2 (5)
3 (51)
4 (11)
5 (136)
6 (140)
7 (50)
9 (2)
10 (140)
11 (193)
12 (119)
13 (154)
14 (53)
15 (2)
16 (5)
17 (153)
18 (162)
19 (149)
20 (175)
21 (74)
23 (5)
24 (163)
25 (169)
26 (152)
27 (186)
28 (69)
29 (4)
30 (4)
31 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Policy
Amgen, Horizon Hit Back at FTC Lawsuit Seeking to Block Merger
The companies have filed their own suit against the Federal Trade Commission, claiming the FTC’s attempt to legally block their $28 billion merger is unconstitutional.
July 5, 2023
·
2 min read
·
Tristan Manalac
Policy
FDA Rejects Amneal’s Extended-Release Parkinson’s Drug
Citing insufficient safety evidence for one of the drug’s main ingredients, the regulator in a Complete Response Letter rejected the company’s application for Parkinson’s disease candidate IPX203.
July 5, 2023
·
2 min read
·
Tristan Manalac
Business
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
The pharmaceutical giant is tapping the world’s largest biomanufacturing facility operated by Samsung Biologics for biosimilar production.
July 5, 2023
·
2 min read
·
Tristan Manalac
Aroga Biosciences Recognized as Top 10 Medical Writing Services Provider by Life Sciences Review
The regulatory medical writing firm is being acknowledged by industry for outstanding service and specialized commitment to its biotechnology and pharmaceutical partners.
July 5, 2023
·
2 min read
Editorial: Gen Z Works for the Money—And You Should, Too
The youngest generation to enter the workforce has mastered working to live, not living to work. Adopting this mindset made me not only more fulfilled, but more successful in my career.
July 5, 2023
·
5 min read
·
Rosemary Scott
Business
Moderna Signs $1B Deal to Develop mRNA Drugs for China
The company has signed a memorandum of understanding and land collaboration agreement to develop medicines exclusively for Chinese use.
July 5, 2023
·
2 min read
·
Connor Lynch
apoQlar secures funding led by YZR Capital, revolutionizes surgical care through partnerships
apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments.
July 5, 2023
·
2 min read
Skanska builds hospital in Lakeland, Florida, USA, for USD 109M, about SEK 1.1 billion
Skanska has signed a contract with an existing client to build a hospital in Lakeland, Florida, USA.
July 5, 2023
·
1 min read
Drug Development
Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study
Sensorion reports further analysis from its Proof of Concept Phase 2a clinical trial of SENS-401 for residual hearing preservation in adult patients following cochlear implantation.
July 5, 2023
·
8 min read
Policy
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
Evotec SE announced that the U.S. Department of Defense has awarded Evotec’s Seattle-based subsidiary, Just - Evotec Biologics, Inc. a contract valued up to $ 74 m for the rapid development of monoclonal antibody -based drug product prototypes targeting orthopoxviruses.
July 5, 2023
·
7 min read
1 of 14
Next